Albert Gris-Oliver

14PUBLICATIONS
189CO-AUTHORS
Solid tumoursHaematological tumoursMolecular targetsPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 14, 2026
The versatile interplay between steatotic liver disease and liver cancer.

Mohammad Rahbari, Albert Gris-Oliver, Pierluigi Ramadori

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Feb 02, 2026
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling.

Anagha Krishna, Alison Meynert, Karamjit Singh Dolt

|Dec 08, 2025
Effective therapeutic targeting of CTNNB1-mutant hepatoblastoma with WNTinib.

Ugne Balaseviciute, Júlia Huguet-Pradell, Jordi Abril-Fornaguera

|Sep 23, 2025
E7386 Enhances Lenvatinib's Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma.

Agavni Mesropian, Albert Gris-Oliver, Ugne Balaseviciute

|Feb 19, 2025
Human-correlated genetic models identify precision therapy for liver cancer.

Miryam Müller, Stephanie May, Holly Hall

Pageof 3

Frequent Collaborators

4 joint publications

Júlia Huguet-Pradell

4 joint publications

Roser Pinyol

4 joint publications

Violeta Serra

3 joint publications

Joaquín Arribas